These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21294913)

  • 1. Adjuvant radiation therapy in metastatic lymph nodes from melanoma.
    Bibault JE; Dewas S; Mirabel X; Mortier L; Penel N; Vanseymortier L; Lartigau E
    Radiat Oncol; 2011 Feb; 6():12. PubMed ID: 21294913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional Radiation Therapy Impacts Outcome for Node-Positive Cutaneous Melanoma.
    Strom T; Torres-Roca JF; Parekh A; Naghavi AO; Caudell JJ; Oliver DE; Messina JL; Khushalani NI; Zager JS; Sarnaik A; Mulé JJ; Trotti AM; Eschrich SA; Sondak VK; Harrison LB
    J Natl Compr Canc Netw; 2017 Apr; 15(4):473-482. PubMed ID: 28404758
    [No Abstract]   [Full Text] [Related]  

  • 3. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.
    Agrawal S; Kane JM; Guadagnolo BA; Kraybill WG; Ballo MT
    Cancer; 2009 Dec; 115(24):5836-44. PubMed ID: 19701906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
    Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
    Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant irradiation for axillary metastases from malignant melanoma.
    Ballo MT; Strom EA; Zagars GK; Bedikian AY; Prieto VG; Mansfield PF; Lee JE; Gershenwald JE; Ross MI
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):964-72. PubMed ID: 11958890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of Postoperative Radiotherapy Using Conventional Fractionation for Lymph Node Metastasis from Cutaneous Melanoma.
    Kim YJ; Song SY; Kim W; Jeong SY; Choi W; Je HU; Lee JS; Choi EK
    Anticancer Res; 2017 Aug; 37(8):4239-4246. PubMed ID: 28739713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.
    Ballo MT; Zagars GK; Gershenwald JE; Lee JE; Mansfield PF; Kim KB; Camacho LH; Hwu P; Ross MI
    Ann Surg Oncol; 2004 Dec; 11(12):1079-84. PubMed ID: 15576833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Locally recurrent and metastatic malignant melanoma. Long-term results and prognostic factors after percutaneous radiotherapy].
    Seegenschmiedt MH; Keilholz L; Pieritz A; Altendorf-Hofmann A; Urban A; Schell H; Hohenberger W; Sauer R
    Strahlenther Onkol; 1999 Sep; 175(9):450-7. PubMed ID: 10518979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial.
    Henderson MA; Burmeister BH; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
    Lancet Oncol; 2015 Sep; 16(9):1049-1060. PubMed ID: 26206146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant postoperative radiotherapy to the cervical lymph nodes in cutaneous melanoma: is there any benefit for high-risk patients?
    Moncrieff MD; Martin R; O'Brien CJ; Shannon KF; Clark JR; Gao K; McCarthy WM; Thompson JF
    Ann Surg Oncol; 2008 Nov; 15(11):3022-7. PubMed ID: 18958539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional control of melanoma neck node metastasis after selective neck dissection with or without adjuvant radiotherapy.
    Hamming-Vrieze O; Balm AJ; Heemsbergen WD; Hooft van Huysduynen T; Rasch CR
    Arch Otolaryngol Head Neck Surg; 2009 Aug; 135(8):795-800. PubMed ID: 19687401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience.
    Seegenschmiedt MH; Keilholz L; Altendorf-Hofmann A; Urban A; Schell H; Hohenberger W; Sauer R
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):607-18. PubMed ID: 10348291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant radiotherapy for cutaneous melanoma: comparing hypofractionation to conventional fractionation.
    Chang DT; Amdur RJ; Morris CG; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1051-5. PubMed ID: 16973303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of Recurrence in Patients with Stage IIIB/C Cutaneous Melanoma of the Head and Neck Following Surgery With and Without Adjuvant Radiation Therapy: Is Isolated Regional Recurrence Salvageable?
    Barbour S; Mark Smithers B; Allan C; Bayley G; Thomas J; Foote M; Burmeister B; Barbour AP
    Ann Surg Oncol; 2015 Nov; 22(12):4052-9. PubMed ID: 25582744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery and adjuvant radiotherapy for cutaneous melanoma considered high-risk for local-regional recurrence.
    Mendenhall WM; Shaw C; Amdur RJ; Kirwan J; Morris CG; Werning JW
    Am J Otolaryngol; 2013; 34(4):320-2. PubMed ID: 23375588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.
    Lee RJ; Gibbs JF; Proulx GM; Kollmorgen DR; Jia C; Kraybill WG
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):467-74. PubMed ID: 10661355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical review of treatment outcomes and patterns of failure with adjuvant radiotherapy in node-positive malignant melanoma.
    Keenan LG; O'Sullivan S; Glynn A; Higgins M; Flavin A; Brennan S
    J Med Imaging Radiat Oncol; 2017 Apr; 61(2):258-262. PubMed ID: 27667733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locally advanced melanoma: results of postoperative hypofractionated radiation therapy.
    Stevens G; Thompson JF; Firth I; O'Brien CJ; McCarthy WH; Quinn MJ
    Cancer; 2000 Jan; 88(1):88-94. PubMed ID: 10618610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant radiotherapy for palpable melanoma metastases to the groin: when to irradiate?
    Gojkovič-Horvat A; Jančar B; Blas M; Zumer B; Karner K; Hočevar M; Strojan P
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):310-6. PubMed ID: 22035662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant radiation therapy after axillary lymphadenectomy for metastatic melanoma: toxicity and local control.
    Strom EA; Ross MI
    Ann Surg Oncol; 1995 Sep; 2(5):445-9. PubMed ID: 7496841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.